MACCARI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 314
NA - Nord America 284
AS - Asia 84
AF - Africa 4
SA - Sud America 4
Totale 690
Nazione #
US - Stati Uniti d'America 281
RU - Federazione Russa 193
IT - Italia 45
IE - Irlanda 25
SG - Singapore 25
HK - Hong Kong 22
CN - Cina 20
SE - Svezia 20
CH - Svizzera 10
FI - Finlandia 10
JO - Giordania 9
GB - Regno Unito 7
IN - India 6
CA - Canada 3
CI - Costa d'Avorio 3
AR - Argentina 2
BR - Brasile 2
DE - Germania 2
NL - Olanda 2
JP - Giappone 1
SD - Sudan 1
TW - Taiwan 1
Totale 690
Città #
Santa Clara 151
Dublin 25
Hong Kong 16
Singapore 16
Chandler 13
Bern 10
Florence 10
Ashburn 9
Altamura 8
Helsinki 8
Lawrence 8
Moscow 5
Shanghai 5
Boston 4
Kent 4
Princeton 4
Abidjan 3
Mumbai 3
New York 3
Toronto 3
Acquaviva delle Fonti 2
Beijing 2
Bremen 2
Buffalo 2
Cipolletti 2
Fairfield 2
Houston 2
Kolkata 2
Lappeenranta 2
Los Angeles 2
Lugo 2
Manchester 2
Maranello 2
Pisa 2
Rimini 2
Rome 2
Seattle 2
Southport 2
São Paulo 2
Andover 1
Ann Arbor 1
Brooklyn 1
Caronno Pertusella 1
Corato 1
Fiesole 1
Genova 1
Glasgow 1
Milan 1
New Taipei City 1
Obata 1
Poplar 1
Pune 1
Romola 1
San Diego 1
San Mateo 1
Scandicci 1
Sesto Fiorentino 1
Torquay 1
Washington 1
Wilmington 1
Xingtai 1
Yubileyny 1
Totale 369
Nome #
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 76
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 75
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 69
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia 63
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera 61
Increased plasma levels of lncrnas linc01268, gas5 and malat1 correlate with negative prognostic factors in myelofibrosis 61
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study 59
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 52
CALR mutation burden in essential thrombocythemia and disease outcome 45
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis 43
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 39
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates 32
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience 18
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia 14
Totale 707
Categoria #
all - tutte 3.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 0 0 0 0 0 13 0 1 3 6
2022/2023129 9 20 7 10 3 19 21 3 14 7 5 11
2023/2024112 5 7 8 5 18 12 1 21 4 10 10 11
2024/2025443 18 59 47 132 187 0 0 0 0 0 0 0
Totale 707